alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 22,376–22,400 of 27,380 studies, newest first · page 896 of 1096.

November 2007 5

  1. 2007-11-01

    An alternative method for estimating efficacy of the AN1792 vaccine for Alzheimer disease

    ✓ Peer-reviewed Treatments Neurology

    Key finding: Published results from the AN1792 trial may have underestimated the effect of vaccine on progression of cerebral atrophy among patients with an antibody response to the vaccine. +2 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2007-11-01

    Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?

    ✓ Peer-reviewed Treatments The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

    Key finding: A comparison of a randomized clinical trial of donepezil in AD patients and this observational study indicates that if appropriate methodological and statistical precautions are undertaken, then results from randomized clinical trials can be predictive with AD patients in clinical practice. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2007-11-01

    Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease

    ✓ Peer-reviewed Treatments Archives of general psychiatry

    Key finding: There were no differences in measures of effectiveness between initiation of active treatments or placebo (which represented watchful waiting) but the placebo group had significantly lower health care costs. +2 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2007-11-01

    Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials

    ✓ Peer-reviewed Treatments PLoS medicine

    Key finding: No significant differences emerged in the probability of conversion from MCI to AD or dementia between the treated groups and the placebo groups. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2007-11-01

    Dietary patterns and risk of dementia: the Three-City cohort study

    ✓ Peer-reviewed Genetics Neurology

    Key finding: Frequent consumption of fruits and vegetables, fish, and omega-3 rich oils may decrease the risk of dementia and Alzheimer disease, especially among ApoE epsilon 4 noncarriers. +3 more findings

    Full summary, score breakdown and related studies → Original source

October 2007 20

  1. 2007-10-29

    Prevalence of dementia in the United States: the aging, demographics, and memory study

    ✓ Peer-reviewed Getting a diagnosis Neuroepidemiology

    Key finding: Dementia prevalence estimates from this first nationally representative population-based study of dementia in the USA to include subjects from all regions of the country can provide essential information for effective planning for the impending healthcare needs of the large and increasing number of individuals at risk for dementia as our population ages.

    Full summary, score breakdown and related studies → Original source

  2. 2007-10-25

    Cognitive training for persons with mild cognitive impairment

    ✓ Peer-reviewed Prevention trials International psychogeriatrics

    Key finding: Furthermore, a large-scale randomized control trial with older adults, independent at entry, indicated that training delayed their cognitive and functional decline over a five-year follow-up. +1 more finding

    Full summary, score breakdown and related studies → Original source

  3. 2007-10-25

    Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies

    ✓ Peer-reviewed How common it is Brain research

    Key finding: The amygdala and hippocampus that were vulnerable to tau or alpha-synuclein pathology demonstrated more severe TDP-43 pathology in AD and DLB cases than in FTLD-U cases. +1 more finding

    Full summary, score breakdown and related studies → Original source

  4. 2007-10-25

    Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS)

    ✓ Peer-reviewed Prevention and risk Stroke

    Key finding: The association between moderate-severe chronic kidney disease and white matter hyperintensity volume highlights the growing importance of kidney disease as a possible determinant of cerebrovascular disease and/or as a marker of microangiopathy. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2007-10-24

    Parkinson's disease: a dual-hit hypothesis

    ✓ Peer-reviewed Mild cognitive impairment Neuropathology and applied neurobiology

    Key finding: Accumulating evidence suggests that sporadic Parkinson's disease has a long prodromal period during which several non-motor features develop, in particular, impairment of olfaction, vagal dysfunction and sleep disorder. +1 more finding

    Full summary, score breakdown and related studies → Original source

  6. 2007-10-24

    The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Neurobiology of aging

    Key finding: The results showed that age by epsilon4 genotype interactions were found for P-tau231 (beta=1.82; p<0.05) and IP (beta=1.6; p<0.05). +2 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2007-10-24

    Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of biological chemistry

    Key finding: Gamma-secretase can be blocked by selective inhibitors but can also be modulated by a subset of non-steroidal anti-inflammatory drugs, including sulindac sulfide. +3 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2007-10-24

    Senile myoclonic epilepsy of Genton: two cases in Down syndrome with dementia and late onset epilepsy

    ✓ Peer-reviewed Down syndrome and Alzheimer's Epilepsy research

    Key finding: Senile myoclonic epilepsy of Genton is a newer epileptic syndrome of the older patients with Down syndrome associated with an Alzheimer-type dementia.

    Full summary, score breakdown and related studies → Original source

  9. 2007-10-22

    The Rotterdam Study: objectives and design update

    ✓ Peer-reviewed Long-term cohort studies European Journal of Epidemiology

    The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of Rotterdam in The Netherlands.

    Full summary, score breakdown and related studies → Original source

  10. 2007-10-22

    BAG-1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein

    ✓ Peer-reviewed Tau biomarkers The Journal of biological chemistry

    Key finding: Research into possible mechanisms leading to the accumulation of modified Tau protein and the possibility of removing Tau protein from the system have revealed that the chaperone protein system can interact with Tau and mediate its degradation. +3 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2007-10-22

    Gene expression profiling in the adult Down syndrome brain

    ✓ Peer-reviewed Down syndrome and Alzheimer's Genomics

    Key finding: The unique profile of up-regulation on chromosome 21, consistent with primary dosage effects, was accompanied by widespread transcriptional disruption. +4 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2007-10-18

    Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load

    ✓ Peer-reviewed Disease mechanisms The Journal of physiology

    Key finding: Clinical manifestations result from selective neuronal degeneration of predominantly GABAergic striatal medium-sized spiny neurons (MSNs). +3 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2007-10-17

    Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease

    ✓ Peer-reviewed Genetics The Journal of biological chemistry

    Key finding: Compelling evidence indicates that excess consumption of sugar-sweetened beverages plays an important role in the epidemic of obesity, a major risk factor for type 2 diabetes mellitus. +4 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2007-10-16

    Adjusted-Dose Warfarin versus Aspirin for Preventing Stroke in Patients with Atrial Fibrillation

    ✓ Peer-reviewed Costs and economics Annals of Internal Medicine

    Key finding: Letters16 October 2007Adjusted-Dose Warfarin versus Aspirin for Preventing Stroke in Patients with Atrial FibrillationRobert G. +4 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2007-10-14

    Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

    ✓ Peer-reviewed Biomarkers Nature Medicine

    Full summary, score breakdown and related studies → Original source

  16. 2007-10-09

    Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment

    ✓ Peer-reviewed Mild cognitive impairment Neuro-degenerative diseases

    Key finding: These results agree with a persistent inflammatory status in AD, reinforcing the hypothesis of a progressive impairment of the immune response in this disorder and suggesting that monocytes may be good targets to study the progression from MCI to AD. +4 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2007-10-04

    Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds

    ✓ Peer-reviewed Risk genes beyond APOE Bioorganic & medicinal chemistry letters

    Key finding: To this aim we designed, synthesized, and tested a series of compounds by introducing halophenylalkylamidic functions on the scaffold of AP2238, which is a dual binding site acetylcholinesterase inhibitor. +1 more finding

    Full summary, score breakdown and related studies → Original source

  18. 2007-10-03

    The hemo-neural hypothesis: on the role of blood flow in information processing

    ✓ Peer-reviewed Vascular contributions Journal of neurophysiology

    Key finding: This novel view of information processing-that includes hemodynamics as an active and significant participant-has implications for understanding neural representation and the construction of accurate brain models.

    Full summary, score breakdown and related studies → Original source

  19. 2007-10-01

    Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines

    ✓ Peer-reviewed Digital health tools Movement disorders : official journal of the Movement Disorder Society

    Key finding: FXTAS is caused by moderate expansions (55-200 repeats; premutation range) of a CGG trinucleotide in the fragile X mental retardation 1 (FMR1) gene, the same gene which causes fragile X syndrome when in the full mutation range (200 or greater CGG repeats). +4 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2007-10-01

    Donepezil for the treatment of agitation in Alzheimer's disease

    ✓ Peer-reviewed Treatments The New England journal of medicine

    Key finding: In this 12-week trial, donepezil was not more effective than placebo in treating agitation in patients with Alzheimer's disease. +2 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →